Replimune Group, Inc. (REPL)

Nasdaq: REPL · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2018

Grade5.0

◀ Past 5.6● Present 4.3▶ Future 5.3

Who runs Replimune Group, Inc.

The record holds no Form 3, 4 or 5 for this company yet, so no officer or director is named.

SI Assistanton REPL · research, not advice